EcoDrugPlus

Ensembl ID : ENSSFOG00015003456
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSSFOG00015011753
Gene Symbol: TTK
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSSFOG00015002038
Gene Symbol: -
Cross references: -
265 Possible Orthologues:

Ensembl ID : ENSSFOG00015011727
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSSFOG00015001021
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSSFOG00015023032
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSSFOG00015008368
Gene Symbol: -
Cross references: -
316 Possible Orthologues:

Ensembl ID : ENSSFOG00015008477
Gene Symbol: -
1 Cross references
318 Possible Orthologues:

Ensembl ID : ENSSFOG00015025684
Gene Symbol: -
Cross references: -
120 Possible Orthologues:

Ensembl ID : ENSSFOG00015013649
Gene Symbol: -
Cross references: -
252 Possible Orthologues:

Ensembl ID : ENSSFOG00015023990
Gene Symbol: -
Cross references: -
142 Possible Orthologues:

Ensembl ID : ENSSFOG00015011499
Gene Symbol: -
Cross references: -
104 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).